122 related articles for article (PubMed ID: 35378463)
1. Novel electrochemical immunosensor for O
Yang H; Ren J; Zhao M; Chen C; Wang F; Chen Z
Bioelectrochemistry; 2022 Aug; 146():108111. PubMed ID: 35378463
[TBL] [Abstract][Full Text] [Related]
2. Amplified electrochemical immunoassay for 5-methylcytosine using a nanocomposite prepared from graphene oxide, magnetite nanoparticles and β-cyclodextrin.
Zhou Y; Jiang W; Wu H; Liu F; Yin H; Lu N; Ai S
Mikrochim Acta; 2019 Jul; 186(8):488. PubMed ID: 31267252
[TBL] [Abstract][Full Text] [Related]
3. Promoter methylation analysis of O6-methylguanine-DNA methyltransferase in glioblastoma: detection by locked nucleic acid based quantitative PCR using an imprinted gene (SNURF) as a reference.
Morandi L; Franceschi E; de Biase D; Marucci G; Tosoni A; Ermani M; Pession A; Tallini G; Brandes A
BMC Cancer; 2010 Feb; 10():48. PubMed ID: 20167086
[TBL] [Abstract][Full Text] [Related]
4. Glycogen synthase kinase 3β inhibition sensitizes human glioblastoma cells to temozolomide by affecting O6-methylguanine DNA methyltransferase promoter methylation via c-Myc signaling.
Pyko IV; Nakada M; Sabit H; Teng L; Furuyama N; Hayashi Y; Kawakami K; Minamoto T; Fedulau AS; Hamada J
Carcinogenesis; 2013 Oct; 34(10):2206-17. PubMed ID: 23715499
[TBL] [Abstract][Full Text] [Related]
5. Clinical trial substantiates the predictive value of O-6-methylguanine-DNA methyltransferase promoter methylation in glioblastoma patients treated with temozolomide.
Hegi ME; Diserens AC; Godard S; Dietrich PY; Regli L; Ostermann S; Otten P; Van Melle G; de Tribolet N; Stupp R
Clin Cancer Res; 2004 Mar; 10(6):1871-4. PubMed ID: 15041700
[TBL] [Abstract][Full Text] [Related]
6. O
Alassiri AH; Alkhaibary A; Al-Sarheed S; Alsufani F; Alharbi M; Alkhani A; Aloraidi A
Ann Saudi Med; 2019; 39(6):410-416. PubMed ID: 31804140
[TBL] [Abstract][Full Text] [Related]
7. Ultrasensitive electrochemical immunoassay for CEA through host-guest interaction of β-cyclodextrin functionalized graphene and Cu@Ag core-shell nanoparticles with adamantine-modified antibody.
Gao J; Guo Z; Su F; Gao L; Pang X; Cao W; Du B; Wei Q
Biosens Bioelectron; 2015 Jan; 63():465-471. PubMed ID: 25129508
[TBL] [Abstract][Full Text] [Related]
8. Prediction of methylguanine methyltransferase promoter methylation in glioblastoma using dynamic contrast-enhanced magnetic resonance and diffusion tensor imaging.
Ahn SS; Shin NY; Chang JH; Kim SH; Kim EH; Kim DW; Lee SK
J Neurosurg; 2014 Aug; 121(2):367-73. PubMed ID: 24949678
[TBL] [Abstract][Full Text] [Related]
9. Voltammetric immunosensor for E-cadherin promoter DNA methylation using a Fe
Khodaei R; Ahmady A; Khoshfetrat SM; Kashanian S; Tavangar SM; Omidfar K
Mikrochim Acta; 2019 Feb; 186(3):170. PubMed ID: 30741341
[TBL] [Abstract][Full Text] [Related]
10. O(6) -methylguanine-DNA methyltransferase (MGMT) promoter methylation and low MGMT-encoded protein expression as prognostic markers in glioblastoma patients treated with biodegradable carmustine wafer implants after initial surgery followed by radiotherapy with concomitant and adjuvant temozolomide.
Lechapt-Zalcman E; Levallet G; Dugué AE; Vital A; Diebold MD; Menei P; Colin P; Peruzzy P; Emery E; Bernaudin M; Chapon F; Guillamo JS
Cancer; 2012 Sep; 118(18):4545-54. PubMed ID: 22359215
[TBL] [Abstract][Full Text] [Related]
11. A Label-Free DNA-Immunosensor Based on Aminated rGO Electrode for the Quantification of DNA Methylation.
Safarzadeh M; Suhail A; Sethi J; Sattar A; Jenkins D; Pan G
Nanomaterials (Basel); 2021 Apr; 11(4):. PubMed ID: 33921234
[TBL] [Abstract][Full Text] [Related]
12. A methylation-specific and SYBR-green-based quantitative polymerase chain reaction technique for O6-methylguanine DNA methyltransferase promoter methylation analysis.
Hattermann K; Mehdorn HM; Mentlein R; Schultka S; Held-Feindt J
Anal Biochem; 2008 Jun; 377(1):62-71. PubMed ID: 18384736
[TBL] [Abstract][Full Text] [Related]
13. Correlation between quantified promoter methylation and enzymatic activity of O6-methylguanine-DNA methyltransferase in glioblastomas.
Kishida Y; Natsume A; Toda H; Toi Y; Motomura K; Koyama H; Matsuda K; Nakayama O; Sato M; Suzuki M; Kondo Y; Wakabayashi T
Tumour Biol; 2012 Apr; 33(2):373-81. PubMed ID: 22274924
[TBL] [Abstract][Full Text] [Related]
14. Extent and patterns of MGMT promoter methylation in glioblastoma- and respective glioblastoma-derived spheres.
Sciuscio D; Diserens AC; van Dommelen K; Martinet D; Jones G; Janzer RC; Pollo C; Hamou MF; Kaina B; Stupp R; Levivier M; Hegi ME
Clin Cancer Res; 2011 Jan; 17(2):255-66. PubMed ID: 21097691
[TBL] [Abstract][Full Text] [Related]
15. Post-transcriptional regulation of O(6)-methylguanine-DNA methyltransferase MGMT in glioblastomas.
Ramakrishnan V; Kushwaha D; Koay DC; Reddy H; Mao Y; Zhou L; Ng K; Zinn P; Carter B; Chen CC
Cancer Biomark; 2011-2012; 10(3-4):185-93. PubMed ID: 22674304
[TBL] [Abstract][Full Text] [Related]
16. A novel electrochemical immunosensor based on Fe
Feng K; Li T; Ye C; Gao X; Yue X; Ding S; Dong Q; Yang M; Huang G; Zhang J
J Dairy Sci; 2022 Mar; 105(3):2108-2118. PubMed ID: 34998563
[TBL] [Abstract][Full Text] [Related]
17. Correlation of O6-methylguanine methyltransferase (MGMT) promoter methylation with clinical outcomes in glioblastoma and clinical strategies to modulate MGMT activity.
Hegi ME; Liu L; Herman JG; Stupp R; Wick W; Weller M; Mehta MP; Gilbert MR
J Clin Oncol; 2008 Sep; 26(25):4189-99. PubMed ID: 18757334
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of the histone H3 lysine 4 methyltransferase MLL4 and the histone H3 lysine 27 demethylase UTX prolonging the overall survival of patients with glioblastoma and a methylated MGMT promoter.
Kim J; Lee SH; Jang JH; Kim MS; Lee EH; Kim YZ
J Neurosurg; 2017 May; 126(5):1461-1471. PubMed ID: 27367247
[TBL] [Abstract][Full Text] [Related]
19. Sensitive electrochemical immunosensor for α-fetoprotein based on graphene/SnO2/Au nanocomposite.
Liu J; Lin G; Xiao C; Xue Y; Yang A; Ren H; Lu W; Zhao H; Li X; Yuan Z
Biosens Bioelectron; 2015 Sep; 71():82-87. PubMed ID: 25889348
[TBL] [Abstract][Full Text] [Related]
20. Fe3O4 magnetic nanoparticles/reduced graphene oxide nanosheets as a novel electrochemical and bioeletrochemical sensing platform.
Teymourian H; Salimi A; Khezrian S
Biosens Bioelectron; 2013 Nov; 49():1-8. PubMed ID: 23708810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
